Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version

Analysis of T cell receptor V repertoires of annular erythema associated with Sjögren’s syndrome


European Journal of Dermatology. Volume 8, Number 4, 248-51, June 1998, Revues


Summary  

Author(s) : Ichiro KATAYAMA, Kiyoshi NISHIOKA, Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1-5-45 Yushima, Bunkyoku, Tokyo 113-0034, Japan..

Summary : Sjögren’s syndrome (SjS) is an autoimmune disorder characterized by lymphocytic infiltration into the lacrimal and salivary glands. Annular erythema has recently been reported to be a specific, cutaneous manifestation associated with SjS. In this study, the T cell receptor (TCR) V gene usage and expansion was examined in annular erythema associated with SjS (AESjS) in 7 patients with primary SjS (5 definite and 2 probable), using reverse transcriptase polymerase chain reaction (RT-PCR) amplification of 22 V gene families. For 4 out of the 7 patients, the TCR V repertoire in lesional skin of AESjS was compared with paired peripheral blood mononuclear cells (PBL). In one case, two lesional tissue specimens biopsied from different sites of AESjS (face and trunk) were examined. As a control, the TCR V repertoire was examined from the lesional skin of butterfly rash biopsied from 3 cases of systemic lupus erythematosus (SLE). Results showed that TCR V 2 was detected in 6 out of the 7 cases of AESjS, although diverse usage was observed. TCR V 2 and 17 (but particularly V 2) were predominantly expressed in AESjS in comparison with paired PBL. In the case which presented AESjS at two separate sites, V 2, 6, 18 and 19 were preferentially expressed in both skin sites as compared with PBL. On the other hand, TCR V 6, 13-2 and 14 were commonly demonstrated in the cutaneous lesions of SLE. These results suggest that (1) the TCR V usage by infiltrating T cells in AESjS is not strictly limited, however, V 2 may play an important role in the induction of AESjS, and that (2) different subsets of TCR V genes are used in the lesional skin of SjS and SLE, which might account for the clinical and histological differences seen in the erythema found in these two autoimmune disorders.

Keywords : Sjögren ’s syndrome, annular erythema, systemic lupus erythematosus, T cell receptor V repertoire.)

Pictures

ARTICLE

Sjögren's syndrome (SjS) is characterized by lymphocytic infiltration into the lacrimal and salivary glands leading to symptomatic dry eyes and mouth [1]. SjS frequently accompanies various kinds of cutaneous manifestations other than extraglandular manifestations, including hypergammaglobulinemic purpura, urticarial vasculitis, autoimmune anhidrosis, and annular erythema [2-4]. Immunohistochemical studies have shown that major dermal infiltrates in the lesional skin of annular erythema associated with SjS (AESjS) consist primarily of CD4+ T lymphocytes [3]. As facial infiltrative erythema can be seen associated with both lupus erythematosus and SjS, we have analyzed the T cell receptor (TCR) Vß repertoire of infiltrating cells in the lesional skin of AESjS using the reverse transcriptase polymerase chain reaction (RT-PCR) to study the mechanism of induction of AESjS and the difference between AESjS and the butterfly-like erythema associated with systemic lupus erythematosus (SLE).

Materials and methods

Patients

Seven patients with AESjS were enrolled in this study (6 females and 1 male, aged 37-69 years), the details of whom are summarized in Table I. Japanese diagnostic criteria for SjS [5] were used. All cases had primary SjS (5 definite and 2 probable) and none of them had a history of having taken any photosensitizing agents. They had not been treated with systemic immunosuppressive drugs when the AESjS had developed. Antinuclear antibodies (ANA) were detected by indirect immunofluorescence using Hep-2 cells. Anti-SS-A and anti-SS-B antibody titers were determined by micro-immunodiffusion using pig spleen for SS-A and rabbit thymus for SS-B as antigens (MBL Co. Ltd., Tokyo, Japan). The biopsied skin tissues from the annular erythema were divided up and one half was snap-frozen in OCT compound (Miles, Elkhart, IN) in liquid nitrogen and immediately stored at ­ 80° C and the other was fixed in 10% formalin solution for routine pathological examination. Histopathological examination showed deep perivascular and periappendageal infiltration by lymphocytes in all cases. As a control, three patients with typical SLE (aged 16-40 years old; 2 females and 1 male) who were diagnosed from clinical, histological and laboratory findings were also examined.

RT-PCR analysis of annular erythema

Peripheral blood mononuclear cells were isolated by Ficoll-Paque density gradient centrifugation (Pharmacia. Uppsala, Sweden). After adherence steps, peripheral blood lymphocytes (PBL) were resuspended in RPMI 1640 supplemented with 7% fetal calf serum (FCS). Total RNA was isolated from fifty, 5-µm frozen biopsied tissue sections and PBL (1 x 106) using RNA zol (Chinna/Biotex, Houston, TX, USA). Then, 100 ng of total RNA was reverse transcribed to cDNA by RAV-2 reverse transcriptase (Takara, Tokyo, Japan). The PCR was performed with 30 µl of a mixture containing 1.5 U Taq polymerase (Perkin Elmer Cetus, CT, USA), 200 M dNTP, 1.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl buffer, pH 8.3, and 20 pmol of Vß family-specific oligonucleotide primers as published by Dunn et al. [6], which were synthesized by a DNA synthesizer (Applied Biosystems model 3919). As internal controls, a pair of 5' sense C alpha-specific primers and 3' antisense C alpha-specific primers were also amplified, as described previously by Choi et al. [7]. The amplification consisted of 30 cycles of 94° C for 1 min, 57° C for 1 min and 72° C for 1 min and 5 sec followed by a final extension for 7 min according to the method of Dunn et al. [6]. PCR products were electrophoresed in 1.7% agarose gel. The gel was stained with 1% ethidium bromide and visualized under ultraviolet light. In preliminary experiments, PCR amplification was performed for 27, 30 and 35 cycles, to ensure that the amplification occurred in a linear range as quantified by a densitometer (EPA-3000, Chemiway, Tokyo). Each intensity was assessed as the ratio with C alpha which was expressed to a similar degree in all experiments, and the relative amount of each TCR Vß gene expression was calculated as a ratio of the total Vß band intensity. Reproducibility of the method was confirmed in preliminary experiments, showing that two separate assays of the same cDNA from a healthy donor resulted in almost identical data. As a control, 3 normal skin biopsies obtained from the face, during plastic surgery procedures were also assayed.

Results

Results of TCR Vß repertoire expression showed diversity, however, TCR Vß 2 was commonly demonstrated in AESjS in 6 out of 7 patients. The TCR Vß expression was also estimated on paired PBL from 4 AESjS patients (Patient 4 (Exp. 1), Patient 5 (Exp. 2), Patient 6 (Exp. 3), Patient 7 (Exp. 4)). Densitometric analysis showed predominant expression of TCR Vß 2 in AESjS as compared to paired PBL (Fig. 1). In one patient (Exp. 4), biopsies were taken from annular erythema occurring on the face and chest. Vß 2, 6, 18 and 19 were strongly detected in both lesional skin samples as compared to PBL (Fig. 1). In a comparative study, the Vß 6, 13-2 and 14 were strongly expressed in the butterfly rash in SLE, as compared to paired PBL. Otherwise, TCR Vß 7 and 20 were demonstrated in 2 SLE patients, and Vß 4, 12, 15, 17 and 18 were also detected. TCR Vß 6 was demonstrated in both SjS and SLE. In normal skin, diverse usage of TCR Vß was noted, and TCR Vß 6, 12, 13-2, 14 and 17 were commonly expressed.

Discussion

AESjS mimics Sweet's syndrome clinically and shows distinct histopathological features resembling Darier's annular erythema. It can be distinguished from subacute cutaneous lupus erythematosus (SCLE) [2-4]. Facial infiltrative erythema is occasionally present in association with both LE and SjS. AESjS has been recently recognized as one of the specific, cutaneous manifestations associated with SjS, however, the mechanism is still unknown. Although the self-antigens in SjS have not yet been identified, retroviral particle alone, or virus-induced products, might be candidates as these self-antigens in the progression of SjS [8-11]. In addition, there is the possibility that the reactive T cells are antigen-driven and/or superantigen-driven. SjS patients occasionally develop annular erythema following upper respiratory infection [12], and it has also been reported that lymphocytes from patients with AESjS showed a strong response to staphylococcal enterotoxin B [13]. In AESjS, cell adhesion molecules on vascular endothelial cells, such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), are up-regulated [14-15]. Therefore these bacterial superantigens may contribute to lymphocyte infiltration into the skin through the expression of cell adhesion molecules.

Recently, Sumida et al. [16] has reported the predominant expression of Vß 2 or Vß 13 on infiltrating T cells in the lips of SjS patients, which may be responsible for triggering the autoimmunity in this disease. They suggest the possibility that previous bacterial infection in the lips of SjS patients led to stimulation and expansion of T cells expressing these two genes. Murata et al. [17] have demonstrated that the TCR Vß 2 gene was predominantly expressed in interstitial nephritis in SjS. They showed that the TCR Vß gene on infiltrating T cells from the kidneys of SjS patients was more restricted than those on infiltrating T cells from labial salivary glands and PBL. On the other hand, diverse usage of TCR Vß was observed in the lacrimal glands in SjS [18]. In this study, the TCR Vß repertoire of infiltrating T cells in the lesional skin of AESjS was not strictly restricted, however, Vß 2, which was preferentially detected in lips or kidneys associated with SjS, was predominantly expressed in 3 cases as compared to paired PBL. Furthermore, it is of note that Vß 2, 6, 18 and 19 genes were strongly detected in AESjS lesional skin from different sites compared to PBL in one patient. In particular, Vß 2 was commonly detected in infiltrating lymphocytes and PBL, and was not commonly detected in lesional skins, suggesting that TCR Vß 2 may contribute to the development of AESjS.

In our study, anti-SS-A antibody was detected in 4 cases (patient 1, 4, 5, 7), Vß 6 was commonly detected and Vß 2 was noted in 3 of these cases. However, Vß 2 and 6 were also detected in cases with negative anti-SS-A antibody.

CONCLUSION

Our results indicate that the TCR Vß repertoire in the lesional skin of AESjS was not so strictly limited to the lips or kidneys in SjS as has been previously reported [16-17]. This may reflect the fact that skin is not always involved in SjS patients. However, Vß 2 was relatively predominantly expressed in AESjS, which may induce the formation of AESjS. It would be interesting to compare the TCR repertoire in different organs from the same patients. Our results also raised the possibility that different usage of TCR Vß gene subsets between SjS and SLE might be associated with the clinical and histological differences between these two conditions, but further studies are necessary.

REFERENCES

1. Bloch KJ, Buchana WW, Wohl MJ, Bunim JJ. Sjögren's syndrome: a clinical, pathological and serological study of sixty-two cases. Medicine 1965; 44: 187-92.

2. Teramoto N, Katayama I, Arai H, Nishioka K, Nishiyama S. Annular erythema: possible association with primary Sjögren syndrome. J Am Acad Dermatol 1989; 20: 596-601.

3. Katayama I, Asai T, Nishioka K, Nishiyama S. Annular erythema associated with primary Sjögren syndrome: analysis of T cell subsets in cutaneous infiltrates. J Am Acad Dermatol 1989; 21: 1218-21.

4. Katayama I, Teramoto N, Arai H, Nishioka K, Nishiyama S. Annular erythema. A comparative study of Sjögren syndrome with subacute cutaneous lupus erythematosus. Int J Dermatol 1991; 30: 635-9.

5. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol 1993; 61 (suppl.): 26-7.

6. Dunn DA, Gadenne AS, Simha S, Lerner EA, Bigby M, Bleicher PA. T cell receptor Vß expression in normal human skin. Proc Natl Acad Sci USA 1993; 90: 1267-71.

7. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1987; 86: 8941-5.

8. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 1989; 169: 2191-8.

9. Green JE, Hinrichs SH, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature 1989; 341: 72-4.

10. Talal N, Dauphine MJ, Dang H, Alexander SS, Hart DJ, Garry RF. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 1990; 30: 774-81.

11. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H. Detection of human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990; 250: 1127-9.

12. Katayama I, Yamamoto T, Otoyama K, Matsunaga T, Nishioka K. Clinical and immunological analysis of annular erythema associated with Sjögren syndrome. Dermatology 1994; 189 (suppl. 1): 14-7.

13. Katayama I, Asai T, Nishiyama S, Nishioka K. Lymphocyte response to staphylococcal enterotoxin B in patients with annular erythema associated with Sjögren syndrome. J Dermatol 1991; 18: 63-8.

14. St Clair EW, Angellilo JC, Singer KH. Expression of cell-adhesion molecules in the salivary gland microenvironment of Sjögren's syndrome. Arthritis Rheum 1992; 35: 62-6.

15. Saito I, Terauchi K, Shimuta M, Nishimura S, Yoshino K, Takeuchi T, Tsubota K, Miyasaka N. Expression of cell adhesion molecules in the salivary and lacrimal gland of Sjögren's syndrome. J Clin Lab Anal 1993; 7: 180-7.

16. Sumida T, Yonaha F, Maeda T, Tanabe E, Koibe T, Tomioka H, Yoshida S. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest 1992; 89: 681-5.

17. Murata H, Kita Y, Sakamoto A, Matsumoto I, Matsumura R, Sugiyama T, Sueishi M, Takabayashi K, Iwamoto I, Saitoh Y, Nishioka K, Sumida T. Limited TCR repertoire of infiltrating T cells in the kidneys of Sjögren's syndrome patients with interstitial nephritis. J Immunol 1995; 155: 4084-9.

18. Mizushima N, Kohsaka H, Tsubota K, Saito I, Miyasaka N. Diverse T cell receptor ß gene usage by infiltrating T cells in the lacrimal glands of Sjögren's syndrome. Clin Exp Immunol 1995; 101: 33-8.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]